Effects of gene delivery on collateral development in chronic hypoperfusion: Diverse effects of angiopoietin-1 versus vascular endothelial growth factor
- 18 August 2004
- journal article
- Published by Elsevier in Journal of the American College of Cardiology
- Vol. 44 (4) , 897-903
- https://doi.org/10.1016/j.jacc.2004.05.046
Abstract
No abstract availableKeywords
This publication has 24 references indexed in Scilit:
- Temporal patterns of gene expression after acute hindlimb ischemia in miceJournal of the American College of Cardiology, 2004
- Regional Angiogenesis With Vascular Endothelial Growth Factor in Peripheral Arterial DiseaseCirculation, 2003
- Molecular regulation of vessel maturationNature Medicine, 2003
- The VIVA TrialCirculation, 2003
- Angiogenic Gene Therapy for Experimental Critical Limb IschemiaCirculation Research, 2002
- Efficacy of intracoronary or intravenous VEGF165in a pig model of chronic myocardial ischemiaJournal of the American College of Cardiology, 2001
- Coadministration of Angiopoietin-1 and Vascular Endothelial Growth Factor Enhances Collateral VascularizationArteriosclerosis, Thrombosis, and Vascular Biology, 2000
- Vascular-specific growth factors and blood vessel formationNature, 2000
- Requisite Role of Angiopoietin-1, a Ligand for the TIE2 Receptor, during Embryonic AngiogenesisPublished by Elsevier ,1996
- Abnormal blood vessel development and lethality in embryos lacking a single VEGF alleleNature, 1996